THE EFFECT OF TOFACITINIB ON SERUM LIPIDS AND CARDIOVASCULAR SAFETY IN PATIENTS WITH ULCERATIVE COLITIS - RESULTS FROM THE TOFACITINIB ULCERATIVE COLITIS CLINICAL PROGRAM

被引：0
|
作者：
Sands, Bruce E.
Taub, Pam R.
Feagan, Brian G.
Armuzzi, Alessandro
Friedman, Gary S.
Moscariello, Michele
Lawendy, Nervin
Pedersen, Ronald D.
Chan, Gary
Nduaka, Chudy I.
Quirk, Daniel
Salese, Leonardo
Su, Chinyu
机构：
来源：
GASTROENTEROLOGY | 2018年 / 154卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Sa1750
引用
收藏
页码：S380 / S380
页数：1
相关论文
共 50 条
  • [21] Tofacitinib in Active Ulcerative Colitis
    Cottone, Mario
    Orlando, Ambrogio
    Papi, Claudio
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (20): : 1960 - 1960
  • [22] Ulcerative Colitis, Bronchiectasis and Tofacitinib
    Ansede-Bordonaba, Guillermo
    Giron-Moreno, Rosa Maria
    Martinez-Vergara, Adrian
    ARCHIVOS DE BRONCONEUMOLOGIA, 2025, 61 (03): : 180 - 181
  • [23] Integrated Safety Analyses of Tofacitinib in Ulcerative Colitis Clinical Trials
    Sandborn, William J.
    Panes, Julian
    D'Haens, Geert
    Sands, Bruce E.
    Su, Chinyu
    Moscariello, Michele
    Jones, Thomas V.
    Pedersen, Ronald D.
    Friedman, Gary S.
    Lawendy, Nervin
    Chan, Gary
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S403 - S404
  • [24] Treating ulcerative colitis with tofacitinib
    Shumeyko, Emma P.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 102 (02) : 170 - 170
  • [25] Tofacitinib for the treatment of ulcerative colitis
    Izzo, Roberta
    Bevivino, Gerolamo
    Monteleone, Giovanni
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2016, 25 (08) : 991 - 997
  • [26] Tofacitinib for the treatment of ulcerative colitis
    Fernandez-Clotet, Agnes
    Castro-Poceiro, Jesus
    Panes, Julian
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2018, 14 (11) : 881 - 892
  • [27] Tofacitinib for the Treatment of Ulcerative Colitis: Analysis of Infection Rates from the Ulcerative Colitis Clinical Programme
    Winthrop, Kevin L.
    Loftus, Edward V. Jr Jr
    Baumgart, Daniel C.
    Reinisch, Walter
    Nduaka, Chudy, I
    Lawendy, Nervin
    Chan, Gary
    Mundayat, Rajiv
    Friedman, Gary S.
    Salese, Leonardo
    Thorpe, Andrew J.
    Su, Chinyu
    JOURNAL OF CROHNS & COLITIS, 2021, 15 (06): : 914 - 929
  • [28] Tofacitinib for the treatment of Ulcerative Colitis: Analysis of malignancy rates from the Ulcerative Colitis clinical programme
    Ungaro, R. C.
    Ciorba, M. A.
    Rogler, G.
    Sharara, A. I.
    Sunna, N.
    Connelly, S. B.
    Mundayat, R.
    Lawendy, N.
    Panes, J.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S357 - S359
  • [29] Tofacitinib Treatment Is Associated With Modest and Reversible Increases in Serum Lipids in Patients With Ulcerative Colitis
    Sands, Bruce E.
    Taub, Pam R.
    Armuzzi, Alessandro
    Friedman, Gary S.
    Moscariello, Michele
    Lawendy, Nervin
    Pedersen, Ronald D.
    Chan, Gary
    Nduaka, Chudy I.
    Quirk, Daniel
    Salese, Leonardo
    Su, Chinyu
    Feagan, Brian G.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2020, 18 (01) : 123 - +
  • [30] Tofacitinib for the Treatment of Ulcerative Colitis: An Update on the Analysis of Malignancy Rates From the Ulcerative Colitis Clinical Program as of May 2019
    Lichtenstein, Gary R.
    Ciorba, Matthew A.
    Rogler, Gerhard
    Sharara, Ala
    Sunna, Nancy
    Mundayat, Rajiv
    Judd, Donna T.
    Lawendy, Nervin
    Panes, Julian
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S464 - S464
12345